Cáncer de mama precoz: el caso de la neoadyuvancia en HER2 positivo - page 21

Neoadjuvant
(EBC)
Adjuvant
(EBC)
Metastatic
(MBC)
1L CLEOPATRA
NEOSPHERE
TRYPHAENA
Pertuzumab:
Broad Development Program in HER2+ Breast Cancer
S
U
R
G
E
R
Y
Early Breast Cancer (EBC)
Data to my talk
Ongoing
APHINITY
Reported/Approved
PHEREXA
1...,11,12,13,14,15,16,17,18,19,20 22,23,24,25,26,27,28,29,30,31,...47
Powered by FlippingBook